the video "daten zur impfstoff-myokarditis" highlights data on rare myocarditis cases post-mrna vaccination, especially in young males, citing studies and arguing for market withdrawal. while risks exist (about 27 cases per million doses in males 12-24, per fda), most recover fully, and covid infection poses a higher heart risk overall; no evidence supports intentional harm claims by yeadon, which are widely debunked as misinformation. benefits still outweigh risks for vaccination.

U.S. Food and Drug Administration

FDA Approves Required Updated Warning in Labeling of mRNA COVID-19 Vac

FDA has required and approved updates to the Prescribing Information for Comirnaty manufactured by Pfizer Inc. and Spikevax manufactured ModernaTX,...

Clinical Considerations: Myocarditis after COVID-19 Vaccines | CDC

Clinical considerations for myocarditis and pericarditis after receipt of mRNA COVID-19 Vaccines among adolescents and young adults.

View quoted note →